Is American Express (AXP) a buy?

=== SUMMARY === - The post analyzes American Express (AXP) as a potential value investment, citing a DCF-derived intrinsic value of $392.41 (~22% upside) and favorable valuation multiples (P/S 2.75, P/E 19.77, PEG 1.12, P/FCF 13.75). - The author argues AXP is a “great business at a fair price,” cheaper than Visa or Mastercard, and notes its status as Berkshire Hathaway’s 2nd-largest holding. - Quality assessment: Well-researched DD with specific financial metrics and a personal DCF model, though it lacks discussion of competitive moats, regulatory risks, or macroeconomic headwinds. === SENTIMENT === BULLISH === TRADE IDEAS === AXP - LONG | confidence: 0.80 | sentiment: +0.70 Speaker: u/Prime_Investor Thesis: 1. THE FACT: AXP trades at a forward P/E of 16.03, PEG of 1.12, and P/FCF of 13.75, with consistent ~14% earnings growth over 1 and 5 years. 2. THE BRIDGE: This combination of moderate valuation and steady growth suggests the market is underpricing AXP’s earnings power, especially relative to higher-multiple peers (V, MA). 3. THE VERDICT: Buy AXP as a long-term compounder with a margin of safety; the 22% upside implied by DCF and Berkshire’s endorsement reinforce the thesis. 4. RISKS: Rising credit defaults, regulatory tightening on fee structures, slower consumer spending, or a shift in payment market share could compress valuation. Debt/Equity at 1.73 is elevated. Timeframe: medium-term Key Points: - Strong earnings growth (14%) with low PEG - Cheaper than Visa/Mastercard on multiples - Berkshire’s 2nd-largest holding adds conviction - DCF implies ~22% upside - Dividend yield low but sustainable (21% payout)